(EMAILWIRE.COM, November 06, 2019 ) The growth of Anastomosis Device Market is primarily driven by the increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, growing demand for minimally invasive surgeries, and technological advancements.

Market Size
The global Anastomosis Device Market is projected to reach USD 2.9 billion by 2024 from an estimated USD 2.1 billion in 2019 at a CAGR of 7.2%.

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5343963

“The surgical staplers segment dominated the anastomosis devices market in 2018.”
Based on the type, the global anastomosis devices market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. In 2018, surgical staplers accounted for the largest share of the market, and this segment is also estimated to grow at the highest CAGR during the forecast period.

“In 2018, the gastrointestinal surgeries segment accounted for the largest share of the anastomosis devices market.”
Based on application, the market is segmented into gastrointestinal surgeries, cardiovascular & thoracic surgeries, and other applications. The gastrointestinal surgeries segment is estimated to grow at the highest CAGR during the forecast period.

“North America accounted for the largest share of the market in 2018”
North America dominated the anastomosis devices market in 2018. The large share of North America in the global market can be attributed to the favorable reimbursement scenario in the US, rising incidence of cancer in the region, and the implementation of a new funding model for Canadian hospitals.

“Hospitals accounted for the largest share of the anastomosis devices market in 2018”
Based on end user, the anastomosis devices market is segmented into hospitals and ambulatory surgery centers (ASCs) & clinics. Hospitals commanded the largest share of the anastomosis devices market in 2018.

Recent Developments
• In 2019, Intuitive Surgical received FDA approval for its SureForm 45 Stapler.
• In 2018, Baxter International Inc. acquired Mallinckrodt Pharmaceutical’s PREVELEAK Surgical Sealant. This acquisition is expected to broaden Baxter’s existing portfolio of advanced surgical sealants.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=5343963